rs1332911302
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 4P and 2B. PM2PM5BP4_Moderate
The NM_014795.4(ZEB2):c.3357G>C(p.Gln1119His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q1119R) has been classified as Pathogenic.
Frequency
Consequence
NM_014795.4 missense
Scores
Clinical Significance
Conservation
Publications
- Mowat-Wilson syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_014795.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ZEB2 | NM_014795.4 | MANE Select | c.3357G>C | p.Gln1119His | missense | Exon 10 of 10 | NP_055610.1 | ||
| ZEB2 | NM_001171653.2 | c.3285G>C | p.Gln1095His | missense | Exon 9 of 9 | NP_001165124.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ZEB2 | ENST00000627532.3 | TSL:1 MANE Select | c.3357G>C | p.Gln1119His | missense | Exon 10 of 10 | ENSP00000487174.1 | ||
| ZEB2 | ENST00000558170.6 | TSL:1 | c.3357G>C | p.Gln1119His | missense | Exon 9 of 9 | ENSP00000454157.1 | ||
| ZEB2 | ENST00000303660.8 | TSL:1 | c.3354G>C | p.Gln1118His | missense | Exon 10 of 10 | ENSP00000302501.4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152140Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74310 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Mowat-Wilson syndrome Uncertain:1
This variant disrupts the p.Gln1119 amino acid residue in ZEB2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16688751). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 534639). This variant has not been reported in the literature in individuals affected with ZEB2-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change replaces glutamine, which is neutral and polar, with histidine, which is basic and polar, at codon 1119 of the ZEB2 protein (p.Gln1119His).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at